BEWARE!!!!!!!!!!!!!!!!!!!!
Corporate Head Office Address
http://www.tgvi.us/
1170 Peachtree Street NE
Suite #1200
Atlanta, GA 30309
United States
Phone: (404) 962-4421
Fax: (404) 885-5701
Primary State of Incorporation: Nevada
Country of Incorporation: USA
Year of Incorporation 2003
Officers:
Stanley Chiang, President/CEO; Maggy Poon, VP Sales & Mktg.; Americo De Rosa, Dir.
Fiscal Year End: April 30
Outstanding Shares: 1,201,600,000 as of 2006-07-31
Estimated Market Cap: Not Available
Authorized Shares: 1,500,000,000 as of 2006-07-31
Float: 100,000 as of 2004-05-19
Number of Shareholders of Record: 37 as of 2004-05-19
Current Capital Change:
shs increased by 100 for 1 split
Ex-Date: 2005-05-19
Record Date: 2005-05-13
Pay Date: 2005-05-18
Dividends:
Company Notes:
Formerly=National Detection Clinics Ltd. until 10-05
Transfer Agent:
Capital Transfer Agency Inc., Toronto, ON M5H 2Y2
http://www.capitaltransferagency.com/
The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases.
TGC Ventures International Inc. is a medically related holding company that is targeting the burgeoning multi-trillion dollar Health Care Services, Medical Devices & Supplies Industry.
Our strategy is to become an emerging leader in the Health Care Services Market and Medical Devices & Supplies Industry. TGC Ventures Internationals growth will be accomplished with the acquisitions of "profitable" companies within these industries. TGC Ventures International will seek companies worldwide that can efficiently provide Health Care Services and/or Medical Devices & Supplies
TGC Ventures International Inc.'s Health Care Services Market Industry will consist of Health Care Services/ Medical Instrument & Devices Application Sectors, Biotechnology and our main focus on Early Detection Cancer Clinics using FDA approved Infra-red Thermal Imaging Technology.
TGC Ventures International Inc. is a medically related holding company that is targeting the burgeoning multi-trillion dollar Health Care Services, Medical Devices & Supplies Industry.
Our strategy is to become an emerging leader in the Health Care Services Market and Medical Devices & Supplies Industry. TGC Ventures Internationals growth will be accomplished with the acquisitions of "profitable" companies within these industries. TGC Ventures International will seek companies worldwide that can efficiently provide Health Care Services and/or Medical Devices & Supplies
TGC Ventures International Inc.'s Health Care Services Market Industry will consist of Health Care Services/ Medical Instrument & Devices Application Sectors, Biotechnology and our main focus on Early Detection Cancer Clinics using FDA approved Infra-red Thermal Imaging Technology
Contact us at TGC Ventures International Inc.
RECENT NEWS-
ROCHESTER, N.Y., Oct. 11, 2005 (PRIMEZONE) -- National Detection Clinics (Pink Sheets:NADE) is pleased to announce it has changed the name of the company to TGC Ventures International Inc. (Pink Sheets:TGVI). The name change is to better reflect the international nature of business activity of the company. The company's focus will be in the National and International Health Care Services Market, Medical Instrument & Devices, and Applications Sectors. TGC Ventures' growth is based upon its acquisition of companies that have the ability to compete successfully in their respective markets. The Company reports that it is encouraged by the progress of recent negotiations and is currently assessing new opportunities to enhance shareholder value.
TGC Ventures International Inc.'s Investor Inquiry Satellite Office Is Now Operational
Feb 3, 2006 10:37:19 AM
ROCHESTER, N.Y., Feb 3, 2006 (PRIMEZONE via COMTEX) --
TGC Ventures International Inc. (Pink Sheets:TGVI), formerly National Detection Clinics, is pleased to announce the company has completed the move of its head office to Hong Kong. We apologize for any inconvenience caused by the relocation. Due to large shareholder base in North America and Europe, the company has decided to keep a satellite office operational in Rochester N.Y.
The office is set up exclusively for shareholder communications. We have been able to reactivate our previous telephone number at 1-585-546-3505. The company recognizes the need for continuous communication and would encourage all shareholders and potential investors to contact us at 1-585-546-3505.
TGC Ventures is in the process of operating Early Detection Clinics in Asia. The clinics use FDA approved Infra-red Thermal Imaging Technology. This non-invasive form of diagnosis determines structure changes in tissues, leading to possible early detection. Currently twenty clinics have been introduced to the technology and are in the process of becoming operational
TGC Ventures International Executes Letter of Intent With Tagalder Environmental Bio-Tech Limited
May 10, 2006
ROCHESTER, N.Y., May 10, 2006 (PRIMEZONE via COMTEX News Network) --
TGC Ventures International (Pink Sheets:TGVI) is pleased to announce it has set forth a letter of intent (LOI) with Tagalder Environmental Bio-Tech Limited ("TGEB") regarding a joint venture agreement.
TGC Ventures International agrees to a 55% joint venture agreement with Tagalder subject to certain terms and conditions. Upon acceptance of this letter, the said percentage is slated to be completed in three transactions and will be announced when each stage is finalized.
About TGC Ventures International Inc.:
TGC Ventures International Inc. is a medically related holding company that is targeting the burgeoning multi-trillion dollar Health Care Services and Medical Devices and Supplies Industry. Value proposition resides in both its knowledge infrastructure and in the host of benefits associated with being a United States publicly listed corporation.
About Tagalder Environmental Bio-Tech:
Tagalder is an international company with investments and operations in North America, South America and Asia. Tagalder is constantly looking for joint venture opportunities in other regions. Tagalder technology is exploring many potential patented/proprietary technologies in China and North America. Many of these technologies are in the early stage of developments but have great market potential in the international market. Tagalder also work with many technology developers in North America or other countries to develop a China market for their products
TGC to Offer Homeopathic Complex for Psoriasis Sufferers
May 24, 2006
ROCHESTER, N.Y., May 24, 2006 (PRIMEZONE via COMTEX News Network) --
TGC Ventures International (Pink Sheets:TGVI) announced that it has contracted CMI Inc. to manufacture and make available a homeopathic product that offers relief for sufferers of psoriasis and other skin conditions.
Psoriasis Complex 7003 offers proven efficacy for skin conditions such as acne, rosaceous and psoriasis.
In studies Complex 7003 has proven to be up to 50% more effective in comparison to pharmaceutical and cosmetic products in reducing inflammation. In a Vivo Test carried out on two panels of 50 volunteers, Complex 7003 again improved the clinical signs of skin sensitivity by more than 60% over a 28-day period versus a placebo.
CMI Inc. has developed some of the most innovative cosmeceutical and nutraceutical formulations on the worldwide market today
TGC Ventures International Introduces New Director
July 20, 2006
ROCHESTER, N.Y., Jul 20, 2006 (PRIMEZONE via COMTEX News Network) --
TGC Ventures International (Pink Sheets:TGVI) announced that Dr. George Grant, M.Sc., Ed.D, C.Chem. has been added to the board of directors. Dr. Grant is a renowned multi talented scientist who pioneered the research on Beta Endorphins in the early eighties. He possesses seven University Degrees, Co-authored 7 best selling books and has lectured to several Fortune 500 companies.
His published articles through the years have drawn thousands of testimonials helping people prevent and reverse many diseases through proper life style and Natural Remedies.
Dr. George Grant, known as "Canada's Wellness Guru," will undoubtedly bring to TGC Ventures Int. a wealth of knowledge and professional business contacts, greatly strengthening TGC Ventures International Management structure.
TGC Ventures International Moves Head Office to Atlanta
October 3, 2006
ATLANTA, Oct 3, 2006 (PrimeZone Media Network via COMTEX News Network) --
TGC Ventures International (Pink Sheets:TGVI) announced that the Company's head office has been moved to Atlanta, Ga. and is now fully operational. The new head office is located at the Midtown Proscenium Center 1170 Peachtree Street NE Suite 1200 Atlanta, Ga. 30309. TGC Ventures can be reached by phone at (404) 962-4421 or fax (404) 885-5701.
TGC Ventures Int. Introduces All-Natural Anti-Aging Product
November 21, 2006
ATLANTA, Nov 21, 2006 (PrimeZone Media Network via COMTEX News Network) --
TGC Ventures International (Pink Sheets:TGVI) has purchased an all-natural anti-aging product.
Anti-Aging Hyaluronic Acid ingestible is an all-natural product that zeros-in on the body's ability to create a balanced and stable condition, and in the process can retain a healthier cell count which brings the benefits that can extend the quality of your life and health.
Anti-Aging Hyaluronic Acid is being produced for TGC Ventures Int. by a well-known manufacturer with a reputation for producing some of the most innovative all-natural formulations on the worldwide market today. The product will be made available in liquid and capsule form. Some additional benefits of the product include:
-- joint lubrication -- reduction of pain and stiffness -- skin moisturization
www.tgvi.us
TGC Ventures International to Introduce All Natural Product for Psoriasis Sufferers in Asian Market
Jan 10, 2007 9:45:09 AM
ATLANTA, Jan 10, 2007 (PrimeNewswire via COMTEX News Network) --
TGC Ventures International (Pink Sheets:TGVI) will begin production of an all-natural product that offers relief for sufferers of psoriasis and other skin conditions. The company intends to develop and introduce the product in Hong Kong and other Asian markets.
TGC Ventures Int., motivated by the growing acceptance of homeopathic and natural remedies world wide, will head up the marketing campaign from their new head office located in Hong Kong.
Psoriasis Complex 7003 offers proven efficacy for skin conditions such as acne, rosacea and psoriasis. In studies, Complex 7003 has proven to be up to 50% more effective in comparison to pharmaceutical and cosmetic products in reducing inflammation. In a Vivo Test carried out on 2 panels of 50 volunteers, Complex 7003 again improved the clinical signs of skin sensitivity by more than 60% over a 28 day period versus a placebo.
www.tgvi.us
TGC Ventures Issues Disclaimer
Jan 10, 2007 5:24:30 PM
ATLANTA, Jan 10, 2007 (PrimeNewswire via COMTEX News Network) --
TGC Ventures International (Pink Sheets:TGVI) issued the following statement:
It has recently come to the Company's attention that an e-mail spam
has been released using the Company's press releases and
information. TGC Ventures International has no knowledge of the
origin and has not authorized or given permission to any groups or
organization regarding this issue.
Stanley Chiang, President TGC Ventures Int
TGC Ventures to Include Anti-Aging Product to Asian Marketing Campaign
Jan 11, 2007 9:45:17 AM
ATLANTA, Jan 11, 2007 (PrimeNewswire via COMTEX News Network) --
TGC Ventures International (Pink Sheets:TGVI) announced that its head office in Hong Kong will include the recently acquired Anti-Aging Hyaluronic Acid product to its Asian marketing campaign.
Anti-Aging Hyaluronic Acid ingestible is an all-natural product that zeros-in on the body's ability to create a balanced and stable condition, and in the process can retain a healthier cell count. Hyaluronic acid is typically found in products intended for the support of connective tissues, most often in joint support and lubrication, skin moisturization and may aid in the reduction of pain and stiffness.
The Company is also considering other natural health products that would enhance market visibility in the targeted Asian markets. More than 50% of the population has used complementary or alternative medicine at least once in Europe and North America.
TGC Ventures International Inc. Directors and Management Team Bios
Mr. Chiang L.F., Chairman
Mr. Chiang L.F. (Stanley) has a strong background in marketing and management specific to business in China and Hong Kong. In addition, Mr. Chiang has abundant experience in retail management and property development. Mr. Chiang has participated in many China ventures in the past 15 years, and has a reputation for being " China" understanding. His connections and relationship in China are invaluable, and is one of Tagalder's major resources for further expansion into China in the coming years.
Miss Tse W. Y., President
Miss Tse W. Y. (Katherine) joined Tagalder Group as Senior Vice President and China Business Development Manager in 2004. Miss Tse has been involved with business on mainland China for nearly 10 years, amassing substantial experience in project investment, mergers and acquisitions, project and corporate restructuring programs.
Miss Tse continues to devote her talents to developing business on mainland China. Through her prolonged efforts, Miss Tse has developed a quality, and highly respected social relationship with China. Miss Tse has been invited by the Fuzhou city of Jiangxi Province as the Mayor's Assistant and Economic Advisor in 2003. Also, Miss Tse was elected as Honor Resident for the city in the same year. Miss Tse has also been invited by Panjin City of Liaoning Province as the Senior Economic Advisor for the government, assisting the city to market overseas promotion and business investment programs.
Miss Tse received her Bachelors degree in construction from Shantou University in 1994 as well as completing the financial planning consultant program from Hong Kong University in 2004.
Ms. Poon Wai Ling, Executive Director
Ms. Poon Wai Ling (Maggy) has been appointed as personal assistant to the CEO of the Tagalder Group. Ms. Poon will provide administrative assistance to each division of our company: Tagalder Global Investment Inc (an SEC reporting issuer company) Tagalder Global Consultation Ltd., and Tagalder Environmental Bio-Tech Co. Ltd.
Ms. Poon has over 10 years cognitive business experience in sales and marketing, advertising and promotion, brand building, business development and IT through a wide variety of industries. Previous to joining Tagalder Group, Ms. Poon was the Business Development Director of Starvision Networks Limited.
Ms. Poon graduated from The University of Dubuque (USA) with a Masters of Business Administration.
http://www.marketwatch.com/charts/int-adv.chart?symb=TGVI&sid=2133728&time=6&startdate=&....
TGVI (.001) Announces Stock Consolidation(1:1000 R/S)
Market Wire "US Press Releases "
ATLANTA, GA -- (MARKET WIRE) -- 03/21/07 -- TGC Ventures International (PINKSHEETS: TGVI) today announced that a stock consolidation was approved by the Company Board of Directors. The stock consolidation will become effective before the opening of business April 9, 2007. TGC Ventures shareholders of record will receive 1(one) new share for every 1000 (one thousand) shares held. TGC Ventures shareholders of record will be issued their new shares and will not be required to surrender their old shares as the company will cancel the old shares automatically. The shares will be paid out on April 20, 2007. www.tgvi.us
About TGC Ventures International Inc.:
TGC Ventures International Inc. is a medically related holding company that is targeting the burgeoning multi-trillion dollar Health Care Services and Medical Devices & Supplies Industry.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this release that are forward-looking statements are based on current expectations and assumptions that are subject to known and unknown risks, uncertainties, or other factors which may cause actual results, performance, or achievements of the company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Actual results could differ materially because of factors such as the effect of general economic and market conditions, entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, technological shifts, and delays in product development and related product release schedules, any of which may cause revenues and income to fall short of anticipated levels. All information in this release is as of the date of this release. The company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations.
TGC Ventures International Inc.
Contact:
Mr. Michael Woo
President
(404) 962-4421
News 
Market Data 
Discover 
